These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16830153

  • 1. A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
    Kawano T, Agata N, Kharbanda S, Avigan D, Kufe D.
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):329-35. PubMed ID: 16830153
    [Abstract] [Full Text] [Related]

  • 2. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
    Iguchi T, Yachide-Noguchi T, Hashimoto Y, Nakazato S, Sagawa M, Ikeda Y, Kizaki M.
    Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
    [Abstract] [Full Text] [Related]

  • 3. 2-(8-Hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl)propionic acid, a small molecule isocoumarin, potentiates dexamethasone-induced apoptosis of human multiple myeloma cells.
    Agata N, Nogi H, Milhollen M, Kharbanda S, Kufe D.
    Cancer Res; 2004 Dec 01; 64(23):8512-6. PubMed ID: 15574755
    [Abstract] [Full Text] [Related]

  • 4. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH.
    Mol Pharmacol; 2004 Jan 01; 65(1):77-84. PubMed ID: 14722239
    [Abstract] [Full Text] [Related]

  • 5. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY.
    Cancer Res; 2004 Jul 01; 64(13):4621-8. PubMed ID: 15231674
    [Abstract] [Full Text] [Related]

  • 6. A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells.
    Sato M, Sagawa M, Nakazato T, Ikeda Y, Kizaki M.
    Int J Oncol; 2007 Jun 01; 30(6):1453-9. PubMed ID: 17487366
    [Abstract] [Full Text] [Related]

  • 7. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK, Han EK, Credo B, Jae HS, Pietenpol JA, Scatena CD, Wu-Wong JR, Frost D, Sham H, Rosenberg SH, Ng SC.
    Cancer Res; 2001 Jul 15; 61(14):5480-5. PubMed ID: 11454695
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells.
    Qi YL, Liao F, Zhao CQ, Lin YD, Zuo MX.
    Acta Pharmacol Sin; 2005 Aug 15; 26(8):1000-8. PubMed ID: 16038635
    [Abstract] [Full Text] [Related]

  • 9. KRIBB3, a novel microtubule inhibitor, induces mitotic arrest and apoptosis in human cancer cells.
    Shin KD, Yoon YJ, Kang YR, Son KH, Kim HM, Kwon BM, Han DC.
    Biochem Pharmacol; 2008 Jan 15; 75(2):383-94. PubMed ID: 17915194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.
    Wu R, Ding W, Liu T, Zhu H, Hu Y, Yang B, He Q.
    Cancer Lett; 2009 Nov 18; 285(1):13-22. PubMed ID: 19647933
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J, Pham NA, Cao MP, Hedley DW.
    Cancer Chemother Pharmacol; 2008 Apr 18; 61(4):669-81. PubMed ID: 17579866
    [Abstract] [Full Text] [Related]

  • 13. [Study on proliferation inhibiting and apoptosis inducing effects of cerulenin on multiple myeloma cells].
    Wang WQ, Zhao XY, Xu GB, Liang Y.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct 18; 27(10):675-7. PubMed ID: 17343199
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells.
    MacCarthy-Morrogh L, Townsend PA, Purohit A, Hejaz HAM, Potter BVL, Reed MJ, Packham G.
    Cancer Res; 2000 Oct 01; 60(19):5441-50. PubMed ID: 11034086
    [Abstract] [Full Text] [Related]

  • 15. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
    Kim SN, Kim NH, Park YS, Kim H, Lee S, Wang Q, Kim YK.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1773-9. PubMed ID: 19428332
    [Abstract] [Full Text] [Related]

  • 16. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
    Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV.
    Clin Cancer Res; 2002 Dec 15; 8(12):3948-54. PubMed ID: 12473611
    [Abstract] [Full Text] [Related]

  • 17. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation.
    Ho SY, Chen WC, Chiu HW, Lai CS, Guo HR, Wang YJ.
    Chem Biol Interact; 2009 May 15; 179(2-3):304-13. PubMed ID: 19159621
    [Abstract] [Full Text] [Related]

  • 18. The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460.
    Cenciarelli C, Tanzarella C, Vitale I, Pisano C, Crateri P, Meschini S, Arancia G, Antoccia A.
    Apoptosis; 2008 May 15; 13(5):659-69. PubMed ID: 18386182
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
    Zhou ZH, Shi Q, Wang JF, Chen YJ, Zhuang YM, Pan JZ, Xu CS, Qi CJ, Zhang XG.
    Apoptosis; 2005 Jan 15; 10(1):123-34. PubMed ID: 15711928
    [Abstract] [Full Text] [Related]

  • 20. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY.
    J Pharmacol Exp Ther; 2007 Oct 15; 323(1):398-405. PubMed ID: 17660383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.